Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in metastatic urothelial cancer with bone metastases
NCT03520231Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2018
- Primary completion
- Dec 2020
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in bone metastasis, sponsored by University Health Network. Started Sep 2018; status: completed.
02
Drugs
denosumab
03
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT03520231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520231.